CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00151-07v1
14/11/1437    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsieh, Y.-F.
Right arrow Articles by Tsay, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsieh, Y.-F.
Right arrow Articles by Tsay, G. J.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, November 2007, p. 1437-1441, Vol. 14, No. 11
1071-412X/07/$08.00+0     doi:10.1128/CVI.00151-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Serum Reactivity against Borrelia burgdorferi OspA in Patients with Rheumatoid Arthritis{triangledown}

Yu-Fan Hsieh,1 Han-Wen Liu,1 Tsai-Ching Hsu,1 James C.-C. Wei,2 Chien-Ming Shih,3 Peter J. Krause,4 and Gregory J. Tsay1,2*

Institute of Immunology,1 Department of Medicine, Chung Shan Medical University, Taichung, Taiwan,2 Department of Parasitology and Tropical Medicine, National Defense Medical Center, Taipei, Taiwan,3 Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Connecticut4

Received 10 April 2007/ Returned for modification 5 July 2007/ Accepted 6 September 2007

Lyme arthritis and rheumatoid arthritis share common clinical features and synovial histology. It is unclear whether they also share similar pathogenesis. Previous studies have shown that the severity and duration of Lyme arthritis correlate directly with serum concentrations of antibody against outer surface protein A (OspA) of the causative pathogen Borrelia burgdorferi. We tested the sera of 68 subjects with rheumatoid arthritis, 147 subjects with other autoimmune diseases, and 44 healthy subjects who had never had Lyme disease, as well as sera of 16 patients who had Lyme disease, for reactivity against the B. burgdorferi OspA protein. The sera of about a quarter of the rheumatoid arthritis patients and a 10th of the autoimmune disease and Lyme disease patients reacted against OspA antigen. Of 50 rheumatoid arthritis patients who could be evaluated for disease severity, a 28-joint count disease activity score of >2.6 was noted for 11 of 15 (73%) patients whose sera reacted against OspA antigen and 13 of 35 (37%; P < 0.05) whose sera were nonreactive. Serum reactivity against OspA antigen is associated with the pathogenesis of rheumatoid arthritis.

* Corresponding author. Mailing address: Department of Medicine and Institute of Immunology, Chung Shan Medical University, 110 Sec.1, Chien Kuo N. Road, Taichung 402, Taiwan. Phone: 886-4-2473-0022, ext. 11705. Fax: 886-4-23248172. E-mail: gjt{at}csmu.edu.tw

{triangledown} Published ahead of print on 19 September 2007.

Clinical and Vaccine Immunology, November 2007, p. 1437-1441, Vol. 14, No. 11
1071-412X/07/$08.00+0     doi:10.1128/CVI.00151-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.